Cita APA

ABDULLAH, M. M., BHAT, A., MOHAMED, A. K., CHING, F. Y., AHMED, N., & GANTOTTI, S. (2016). Gefitinib as first line therapy in Malaysian patients with EGFR mutation-positive non-small-cell lung cancer: A single-center retrospective study. Oncol Lett.

Citación estilo Chicago

ABDULLAH, MATIN MELLOR, AMIT BHAT, AHMAD KAMAL MOHAMED, FOO YOKE CHING, NIDA AHMED, y SANDEEP GANTOTTI. "Gefitinib As First Line Therapy in Malaysian Patients With EGFR Mutation-positive Non-small-cell Lung Cancer: A Single-center Retrospective Study." Oncol Lett 2016.

Cita MLA

ABDULLAH, MATIN MELLOR, et al. "Gefitinib As First Line Therapy in Malaysian Patients With EGFR Mutation-positive Non-small-cell Lung Cancer: A Single-center Retrospective Study." Oncol Lett 2016.